IMMUNOMEDICS

World Rank (Dec-25-2022)
993
World Rank (Jan-07-2022)
993
Market Cap (Jan-07-2022)
21.000 Billion USD
World Rank (Jan-01-2021)
881
Market Cap (Jan-01-2021)
21.000 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-89 Million USD
Annual Results for Year ending in
Dec-2020 month
Headquarters State / City
New Jersey
Headquarters Country
USA
Company Business
Healthcare
Biotechnology
Technology
HealthCare Products
Stock Exchange
Nasdaq
Company Rank in Country in 2022
Company Rank in USA in 2022 is 420
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 361
Rank in Country (Jan-2020)
Rank in USA in 2020 is 957
Number of Employees
366
Employee Count as on Date
As on 2019
Company Website:
IMMUNOMEDICS INC
About Company Business:

IMMUNOMEDICS is a biotechnology company related to cancer drugs. Headquarters is in New Jersey, USA.

It engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe.

Gilead Sciences acquired Immunomedics for 21 Billion USD in 2020.

 

Founded Year
1982

Comments

Gilead Sciences planning to acquire IMMUNOMEDICS for 21B USD

IMMUNOMEDICS share price surged by 97% on Monday trade as Gilead Sciences planning to acquire IMMUNOMEDICS for 21 Billion USD.

IMMUNOMEDICS is a biotechnology company related to cancer drugs. Headquarters is in New Jersey, USA.

Tue, 15/09/2020 - 09:40

Share it on Social Media